Helen Maunder

Title: Helen Maunder - Innovator in Retroviral Vector Technology

Introduction

Helen Maunder is a distinguished inventor based in Bicester, GB. She has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors. Her innovative work has led to advancements in gene therapy and related applications.

Latest Patents

Helen holds a patent for a retroviral vector, which is a cell designed for producing retroviral vectors. This invention comprises nucleic acid sequences encoding essential components such as gag-pol, env, and the RNA genome of the retroviral vector. Additionally, the patent includes provisions for optional rev or a functional substitute, with at least two nucleic acid sequences located at the same genetic locus and arranged in reverse and/or alternating orientations. This patent showcases her expertise and creativity in genetic engineering.

Career Highlights

Helen Maunder is currently employed at Oxford Biomedica (UK) Limited, where she continues to push the boundaries of biotechnological research. Her work at this leading company has allowed her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Hannah Stewart and Kyriacos Andreou Mitrophanous. Their collective efforts contribute to the innovative environment at Oxford Biomedica, fostering advancements in gene therapy and related technologies.

Conclusion

Helen Maunder's contributions to retroviral vector technology exemplify her dedication to innovation in biotechnology. Her patent and ongoing work at Oxford Biomedica highlight her role as a key figure in the advancement of gene therapy.